as 11-15-2024 4:00pm EST
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.
Founded: | 2021 | Country: | United Kingdom |
Employees: | 5 | City: | N/A |
Market Cap: | 2.0M | IPO Year: | 2022 |
Target Price: | N/A | AVG Volume (30 days): | 175.8K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -108.84 | EPS Growth: | N/A |
52 Week Low/High: | $1.22 - $56.80 | Next Earning Date: | 01-04-2025 |
Revenue: | $2,508,317 | Revenue Growth: | -6.24% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AKAN Breaking Stock News: Dive into AKAN Ticker-Specific Updates for Smart Investing
Newsfile
6 days ago
Newsfile
a month ago
Newsfile
2 months ago
Newsfile
2 months ago
MT Newswires
2 months ago
Newsfile
5 months ago
Newsfile
5 months ago
Newsfile
5 months ago
The information presented on this page, "AKAN Akanda Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.